Exagen to announce fourth quarter and full year financial results on march 22, 2022

San diego, march 08, 2022 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended december 31, 2021 after the market close on tuesday, march 22, 2022. ron rocca, exagen's president and chief executive officer, kamal adawi, chief financial officer, and mark hazeltine, chief operating officer, will host a conference call to review the company's results at 4:30 pm et (1:30 pm pt).
XGN Ratings Summary
XGN Quant Ranking